NOS2 and Alzheimer disease: In vivo studies involving AD models show that RJ enhanced the endogenous production of antioxidants, increasing superoxide dismutase (SOD) by up to 27% and reducing free radicals such as ROS, NOS, and malonaldehyde (MDA) in the cortex and hippocampus [70,95].